Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multiple sclerosis. Chlamydia hypothesis in debate].

T Derfuss1, R Hohlfeld, E Meinl

  • 1Abteilung für Neuroimmunologie, Max-Planck-Institut für Neurobiologie, Am Klopferspitz 18A, 82152 Martinsried.

Der Nervenarzt
|November 2, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correcting gut dysbiosis can ameliorate inflammation and promote remyelination in multiple sclerosis - Commentary.

Multiple sclerosis (Houndmills, Basingstoke, England)·2021
Same author

Characteristics of improvements in balance control using vibro-tactile biofeedback of trunk sway for multiple sclerosis patients.

Journal of the neurological sciences·2021
Same author

The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical·2020
Same author

Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatment.

European journal of neurology·2020
Same author

Magnetic resonance imaging in immune-mediated myelopathies.

Journal of neurology·2019
Same author

Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis.

Multiple sclerosis and related disorders·2018
Same journal

[When brain abscesses run in the family…].

Der Nervenarzt·2026
Same journal

[Digital health applications and adherence in depression: a qualitative study from the perspective of healthcare providers].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

[Rare genetic diseases with frequent mental symptoms].

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
Same journal

Der Nervenarzt·2026
See all related articles

Multiple sclerosis (MS) patients show antibodies against Chlamydia pneumoniae, but these are not the cause of MS. Oligoclonal bands in cerebrospinal fluid (CSF) of MS patients do not target Chlamydia, suggesting no causal link.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Context:

  • A potential link between Chlamydia pneumoniae infection and multiple sclerosis (MS) has been proposed.
  • Previous studies yielded conflicting results regarding C. pneumoniae presence in MS central nervous system (CNS) tissue.
  • Elevated intrathecal antibody production against C. pneumoniae is observed in some MS patients.

Purpose:

  • To investigate whether oligoclonal bands in the cerebrospinal fluid (CSF) of MS patients recognize Chlamydia pneumoniae antigens.
  • To determine if C. pneumoniae plays a causal role in the pathogenesis of multiple sclerosis.

Summary:

  • Affinity-mediated immunoblots revealed that oligoclonal bands in MS patient CSF are not directed against Chlamydia antigens.
  • In contrast, immunoglobulins from neuroborreliosis patients strongly reacted against Borrelia antigens.

Related Experiment Videos

  • The observed intrathecal antibody production against C. pneumoniae in MS patients is likely part of a broader, polyspecific immune response, not specific to this pathogen.

    • Impact:

    • Challenges the hypothesis that Chlamydia pneumoniae infection is a direct cause of multiple sclerosis.
    • Suggests that intrathecal antibody responses in neurological diseases can be polyspecific.
    • Highlights the importance of specific antigen targeting for confirming infectious agents in CNS pathogenesis.